Impact of myocardial perfusion abnormality on prognosis in patients with non-ischemic dilated cardiomyopathy

Journal of Cardiology

Volumn 56, Issue 3, 2010, Pages 280-286

  Sobajima, Mitsuo ^a   Nozawa, Takashi ^a   Suzuki, Takayuki ^a   Ohori, Takashi ^a   Shida, Takuya ^a   Matsuki, Akira ^a   Inoue, Hiroshi ^a  

^a UNIVERSITY OF TOYAMA   (Japan)

Author keywords

Myocardial perfusion; Non ischemic dilated cardiomyopathy; Radionuclide; Ventricular arrhythmias

Indexed keywords

TETROFOSMIN TC 99M;

ADULT; ARTICLE; CONGESTIVE CARDIOMYOPATHY; ELECTROCARDIOGRAM; FEMALE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE PERFUSION; HEART SCINTISCANNING; HEART VENTRICLE ARRHYTHMIA; HEMODYNAMIC PARAMETERS; HUMAN; IMAGE RECONSTRUCTION; MAJOR CLINICAL STUDY; MALE; MORTALITY; NON ISCHEMIC DILATED CARDIOMYOPATHY; PROGNOSIS; RETROSPECTIVE STUDY; SCINTIGRAPHY; SCINTILLATION CAMERA; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SURVIVAL RATE;

ADULT; AGED; CARDIOMYOPATHY, DILATED; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL PERFUSION IMAGING; PROGNOSIS; RETROSPECTIVE STUDIES;

EID: 78049450585     PISSN: 09145087     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jjcc.2010.06.008     Document Type: Article

References (34)

1. Bach D.S., Beanlands R.S., Schwaiger M., Armstrong W.F. Heterogeneity of ventricular function and myocardial oxidative metabolism in nonischemic dilated cardiomyopathy. J Am Coll Cardiol 1995, 25:1258-1262.
2. Hayashida W., Kumada T., Nohara R., Tanino H., Kambayashi M., Ishikawa N., Nakamura Y., Himura Y., Kawai C. Left ventricular regional wall stress in dilated cardiomyopathy. Circulation 1990, 82:2075-2083.
3. Fujita N., Duerinckx A.J., Higgins C.B. Variation in left ventricular regional wall stress with cine magnetic resonance imaging: normal subjects versus dilated cardiomyopathy. Am Heart J 1993, 125:1337-1345.
4. Juilliere Y., Marie P.Y., Danchin N., Gillet C., Paille F., Karchier G., Bertrand A., Cherrier F. Radionuclide assessment of regional differences in left ventricular wall motion and myocardial perfusion in idiopathic dilated cardiomyopathy. Eur Heart J 1993, 14:1163-1169.
5. O'Neill J.O., McCarthy P.M., Brunken R.C., Buda T., Hoercher K., Young J.B., Starling R.C. PET abnormalities in patients with nonischemic cardiomyopathy. J Card Fail 2004, 10:244-249.
6. Iskandrian A.S., Hakki A.H., Kane S. Resting thallium-201 myocardial perfusion patterns in patients with severe left ventricular dysfunction: differences between patients with primary cardiomyopathy, coronary artery disease, or acute myocardial function. Am Heart J 1986, 111:760-767.
7. Watanabe M., Gotoh K., Nagashima K., Uno Y., Noda T., Nishigaki K., Takemura G., Kanoh M., Yasuda N., Ohno Y., Minatoguchi S., Fujiwara H. Relationship between thallium-201 myocardial SPECT and findings of endomyocardial biopsy specimens in dilated cardiomyopathy. Ann Nucl Med 2001, 15:13-19.
8. Hara Y., Inoue K., Ogimoto A., Ohtsuka T., Shigematsu Y., Nakata S., Higaki J. Effect of beta-blocker therapy on myocardial perfusion defects in thallium-201 scintigraphy in patients with dilated cardiomyopathy. Cardiology 2005, 104:16-21.
9. Doi Y.L., Chikamori T., Tukata J., Yonezawa Y., Poloniecki J.D., Ozawa T., McKenna W.J. Prognostic value of thallium-201 perfusion defects in idiopathic dilated cardiomyopathy. Am J Cardiol 1991, 67:188-193.
10. Fauchier L., Eder V., Casset-Senon D., Marie O., Babuty D., Cosnay P., Fauchier J.P. Segmental wall motion abnormalities in idiopathic dilated cardiomyopathy and their effect on prognosis. Am J Cardiol 2004, 93:1504-1509.
11. Wallis D.E., O'Connell J.B., Henkin R.E., Costanzo-Nordin M.R., Scanlon P.J. Segmental wall motion abnormalities in dilated cardiomyopathy: a common finding and good prognostic sign. J Am Coll Cardiol 1984, 4:674-679.
12. Aepfelbacher F.C., Johnson R.B., Schwartz J.G., Chen L., Parker R.A., Parker J.A., Danias P.G. Validation of a model of left ventricular segmentation for interpretation of SPET myocardial perfusion images. Eur J Nucl Med 2001, 28:1624-1629.
13. Young A.A., Dokos S., Powell K.A., Sturm B., McCulloch A.D., Starling R.C., McCarthy P.M., White R.D. Regional heterogeneity of function in nonischemic dilated cardiomyopathy. Cardiovasc Res 2001, 49:308-318.
14. Nowak B., Stellbrink C., Schaefer W.M., Sinha A.M., Breithardt O.A., Kaiser H.J., Reinartz P., Hanrath P., Buell U. Comparison of regional myocardial blood flow and perfusion in dilated cardiomyopathy and left bundle branch block: role of wall thickening. J Nucl Med 2004, 45:414-418.
15. Skalidis E.I., Parthenakis F.I., Patrianakos A.P., Hamilos M.I., Vardas P.E. Regional coronary flow and contractile reserve in patients with idiopathic dilated cardiomyopathy. J Am Coll Cardiol 2004, 44:2027-2032.
16. van den Heuvel A.F., van Veldhuisen D.J., van der Wall E.E., Blanksma P.K., Siebelink H.M., Vaalburg W.M., van Gilst W.H., Crijns H.J. Regional myocardial blood flow reserve impairment and metabolic changes suggesting myocardial ischemia in patients with idiopathic dilated cardiomyopathy. J Am Coll Cardiol 2000, 35:19-28.
17. Hassan N., Escanyé J.M., Juillière Y., Marie P.Y., David N., Olivier P., Ayalew A., Karcher G., Stolz J.F., Bertrand A. 201Tl SPECT abnormalities, documented at rest in dilated cardiomyopathy, are related to a lower than normal myocardial thickness but not to an excess in myocardial wall stress. J Nucl Med 2002, 43:451-457.
18. Li L.X., Nohara R., Okuda K., Hosokawa R., Hata T., Tanaka M., Matsumori A., Fujita M., Tamaki N., Konishi J., Sasayama S. Comparative study of 201Tl-scintigraphic image and myocardial pathologic findings in patients with dilated cardiomyopathy. Ann Nucl Med 1996, 10:307-314.
19. Dunn R.F., Uren R.F., Sadick N., Bautovich G., McLaughlin A., Hiroe M., Kelly D.T. Comparison of thallium-201 scanning in idiopathic dilated cardiomyopathy and severe coronary artery disease. Circulation 1982, 66:804-810.
20. O'Gara P.T., Bonow R.O., Maron B.J., Damske B.A., Van Lingen A., Bacharach S.L., Larson S.M., Epstein S.E. Myocardial perfusion abnormalities in patients with hypertrophic cardiomyopathy: assessment with thallium-201 emission computed tomography. Circulation 1987, 76:1214-1223.
21. Cannon R.O., Rosing D.R., Maron B.J., Leon M.B., Bonow R.O., Watson R.M., Epstein S.E. Myocardial ischemia in patients with hypertrophic cardiomyopathy: contribution of inadequate vasodilator reserve and elevated left ventricular filling pressures. Circulation 1985, 71:234-243.
22. Yamaguchi S., Tsuiki K., Hayasaka M., Yasui S. Segmental wall motion abnormalities in dilated cardiomyopathy: hemodynamic characteristics and comparison with thallium-201 myocardial scintigraphy. Am Heart J 1987, 113:1123-1128.
23. McCrohon J.A., Moon J.C.C., Prasad S.K., McKenna W.J., Lorenz C.H., Coats A.J.S., Pennell D.J. Differentiation of heart failure related to dilated cardiomyopathy and coronary artery disease using gadolinium-enhanced cardiovascular magnetic resonance. Circulation 2003, 108:54-59.
24. Assomull R.G., Prasad S.K., Lyne J., Smith G., Burman E.D., Khan M., Sheppard M.N., Poole-Wilson P.A., Pennell D.J. Cardiovascular magnetic resonance, fibrosis, and prognosis in dilated cardiomyopathy. J Am Coll Cardiol 2006, 48:1977-1985.
25. Wu K.C., Weiss R.G., Thiemann D.R., Kitagawa K., Schmidt A., Dalal D., Lai S., Bluemke D.A., Gerstenblith G., Marban E., Tomaselli G.F., Lima J.A.C. Late gadolinium enhancement by cardiovascular magnetic resonance heralds an adverse prognosis in nonischemic cardiomyopathy. J Am Coll Cardiol 2008, 51:2414-2421.
26. Tigen K., Karaahmet T., Kirma C., Dundar C., Pala S., Isiklar I., Cevik C., Kilicgedik A., Basaran Y. Diffuse late gadolinium enhancement by cardiovascular magnetic resonance predicts significant intraventricular systolic dyssynchrony in patients with non-ischemic dilated cardiomyopathy. J Am Soc Echocardiogr 2010, 23:416-422.
27. Xiao H.B., Brecker S.J., Gibson D.G. Effects of abnormal activation on the time course of the left ventricular pressure pulse in dilated cardiomyopathy. Br Heart J 1992, 68:403-407.
28. Fried A.G., Parker A.B., Newton G.E., Parker J.D. Electrical and hemodynamic correlates of the maximal rate of pressure increase in the human left ventricle. J Card Fail 1999, 5:8-16.
29. Unverferth D.V., Magorien R.D., Moeschberger M.L., Baker P.B., Fetters J.K., Leier C.V. Factors influencing the one-year mortality of dilated cardiomyopathy. Am J Cardiol 1984, 54:147-152.
30. Xiao H.B., Roy C., Fujimoto S., Gibson D.G. Natural history of abnormal conduction and its relation to prognosis in patients with dilated cardiomyopathy. Int J Cardiol 1996, 53:163-170.
31. Nowak B., Sinha A.M., Schaefer W.M., Koch K.C., Kaiser H.J., Hanrath P., Buell U., Stellbrink C. Cardiac resynchronization therapy homogenizes myocardial glucose metabolism and perfusion in dilated cardiomyopathy and left bundle branch block. J Am Coll Cardiol 2003, 41:1523-1528.
32. Sundell J., Engblom E., Koistinen J., Ylitalo A., Naum A., Stolen K.Q., Kalliokoski R., Nekolla S.G., Airaksinen K.E., Bax J.J., Knuuti J. The effects of cardiac resynchronization therapy on left ventricular function, myocardial energetics, and metabolic reserve in patients with dilated cardiomyopathy and heart failure. J Am Coll Cardiol 2004, 43:1027-1033.
33. Soejima K., Stevenson W.G., Sapp J.L., Selwyn A.P., Couper G., Epstein L.M. Endocardial and epicardial radiofrequency ablation of ventricular tachycardia associated with dilated cardiomyopathy: the importance of low-voltage scars. J Am Coll Cardiol 2004, 43:1834-1842.
34. Kubo T., Matsumura Y., Kitaoka H., Okawa M., Hirota T., Hamada T., Hitomi N., Hoshikawa E., Hayato K., Shimizu Y., Yamasaki N., Yabe T., Nishinaga M., Takata J., Doi Y. Improvement in prognosis of dilated cardiomyopathy in the elderly over the past 20 years. J Cardiol 2008, 52:111-117.